Norbert Barlicki University Clinical Hospital No.1, Lodz
About Norbert Barlicki University Clinical Hospital No.1, Lodz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Genzyme, a Sanofi Company
2
Clinical Trials at Norbert Barlicki University Clinical Hospital No.1, Lodz
During the past decade, Norbert Barlicki University Clinical Hospital No.1, Lodz conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
2007-08-01
2011-04-01
Completed
581
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
2007-10-01
2011-09-01
Completed
840
Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
2016-05-16
2020-08-18
Completed
121
Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment
2016-06-09
2018-06-08
Completed
347
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
2017-01-17
2019-08-12
Completed
663
An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis
2018-01-09
2021-07-27
Completed
69
A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
2019-04-16
2022-08-30
Completed
436
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Norbert Barlicki University Clinical Hospital No.1, Lodz"
#1 collaborator was "Bayer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Norbert Barlicki University Clinical Hospital No.1, Lodz
According to Clinical.Site data, the most researched conditions in "Norbert Barlicki University Clinical Hospital No.1, Lodz" are
"Lung Diseases, Interstitial" (2 trials), "Lupus Nephritis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Norbert Barlicki University Clinical Hospital No.1, Lodz" in a lesser frequency.
Clinical Trials Intervention Types at Norbert Barlicki University Clinical Hospital No.1, Lodz
Most popular intervention types in "Norbert Barlicki University Clinical Hospital No.1, Lodz" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Interferon beta-1a" (2 trials), "Nintedanib" (2 trials), "Alemtuzumab" (1 trials) and "Alemtuzumab 12 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Norbert Barlicki University Clinical Hospital No.1, Lodz
The vast majority of trials in "Norbert Barlicki University Clinical Hospital No.1, Lodz" are
7 trials for "All" genders.
Clinical Trials Status at Norbert Barlicki University Clinical Hospital No.1, Lodz
Currently, there are NaN active trials in "Norbert Barlicki University Clinical Hospital No.1, Lodz".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Norbert Barlicki University Clinical Hospital No.1, Lodz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Norbert Barlicki University Clinical Hospital No.1, Lodz, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".